These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1142 related items for PubMed ID: 18603077

  • 21. Outcomes of preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil followed by esophagectomy in patients with resectable node-positive esophageal cancer.
    Watanabe M, Baba Y, Yoshida N, Ishimoto T, Nagai Y, Iwatsuki M, Iwagami S, Baba H.
    Ann Surg Oncol; 2014 Sep; 21(9):2838-44. PubMed ID: 24715216
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Which is the optimal response criteria for evaluating preoperative treatment in esophageal cancer: RECIST or histology?
    Kurokawa Y, Shibata T, Ando N, Seki S, Mukaida H, Fukuda H.
    Ann Surg Oncol; 2013 Sep; 20(9):3009-14. PubMed ID: 23504143
    [Abstract] [Full Text] [Related]

  • 24. Initial stage affects survival even after complete pathologic remission is achieved in locally advanced esophageal cancer: analysis of 70 patients with pathologic major response after preoperative chemoradiotherapy.
    Kim MK, Cho KJ, Park SI, Kim YH, Kim JH, Song HY, Shin JH, Jung HY, Lee GH, Choi KD, Song HJ, Ryu JS, Kim SB.
    Int J Radiat Oncol Biol Phys; 2009 Sep 01; 75(1):115-21. PubMed ID: 19251379
    [Abstract] [Full Text] [Related]

  • 25. Adjuvant chemotherapy after esophagectomy: is there a role in the treatment of the lymph node positive thoracic esophageal squamous cell carcinoma?
    Lyu X, Huang J, Mao Y, Liu Y, Feng Q, Shao K, Gao S, Jiang Y, Wang J, He J.
    J Surg Oncol; 2014 Dec 01; 110(7):864-8. PubMed ID: 24976079
    [Abstract] [Full Text] [Related]

  • 26. Interval between neoadjuvant chemoradiotherapy and surgery for esophageal squamous cell carcinoma: does delayed surgery impact outcome?
    Chiu CH, Chao YK, Chang HK, Tseng CK, Chan SC, Liu YH, Chen WH.
    Ann Surg Oncol; 2013 Dec 01; 20(13):4245-51. PubMed ID: 23959050
    [Abstract] [Full Text] [Related]

  • 27. Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer.
    van Heijl M, Omloo JM, van Berge Henegouwen MI, Hoekstra OS, Boellaard R, Bossuyt PM, Busch OR, Tilanus HW, Hulshof MC, van der Gaast A, Nieuwenhuijzen GA, Bonenkamp HJ, Plukker JT, Cuesta MA, Ten Kate FJ, Pruim J, van Dekken H, Bergman JJ, Sloof GW, van Lanschot JJ.
    Ann Surg; 2011 Jan 01; 253(1):56-63. PubMed ID: 21233607
    [Abstract] [Full Text] [Related]

  • 28. Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma.
    Makino T, Doki Y, Miyata H, Yasuda T, Yamasaki M, Fujiwara Y, Takiguchi S, Higuchi I, Hatazawa J, Monden M.
    Surgery; 2008 Nov 01; 144(5):793-802. PubMed ID: 19081023
    [Abstract] [Full Text] [Related]

  • 29. Prediction of Recurrence and Mortality of Locally Advanced Esophageal Cancer Patients Using Pretreatment F-18 FDG PET/CT Parameters: Intratumoral Heterogeneity, SUV, and Volumetric Parameters.
    Chang S, Kim SJ.
    Cancer Biother Radiopharm; 2016 Feb 01; 31(1):1-6. PubMed ID: 26844846
    [Abstract] [Full Text] [Related]

  • 30. Role of surgical resection in complete responders on FDG-PET after chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
    Jeong Y, Kim JH, Kim SB, Yoon DH, Park SI, Kim YH, Kim HR, Jung HY, Lee GH, Ryu JS.
    J Surg Oncol; 2014 Apr 01; 109(5):472-7. PubMed ID: 24301552
    [Abstract] [Full Text] [Related]

  • 31. [A prospective comparison between surgery alone and postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma].
    Cao XF, Lü J, Zhu B, An HY, Wang S, Wu BC, Ji L, Tao L, Wang DD.
    Zhonghua Zhong Liu Za Zhi; 2010 Jun 01; 32(6):452-5. PubMed ID: 20819489
    [Abstract] [Full Text] [Related]

  • 32. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications.
    Choi JY, Jang HJ, Shim YM, Kim K, Lee KS, Lee KH, Choi Y, Choe YS, Kim BT.
    J Nucl Med; 2004 Nov 01; 45(11):1843-50. PubMed ID: 15534053
    [Abstract] [Full Text] [Related]

  • 33. Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma.
    Konski AA, Cheng JD, Goldberg M, Li T, Maurer A, Yu JQ, Haluszka O, Scott W, Meropol NJ, Cohen SJ, Freedman G, Weiner LM.
    Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):358-63. PubMed ID: 17532577
    [Abstract] [Full Text] [Related]

  • 34. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer.
    Levine EA, Farmer MR, Clark P, Mishra G, Ho C, Geisinger KR, Melin SA, Lovato J, Oaks T, Blackstock AW.
    Ann Surg; 2006 Apr 01; 243(4):472-8. PubMed ID: 16552197
    [Abstract] [Full Text] [Related]

  • 35. Usefulness of 18f-Fluorodeoxyglucose Positron Emission Tomography for Predicting the Pathological Response of Neoadjuvant Chemoradiotherapy for T4 Esophageal Squamous Cell Carcinoma.
    Sakai M, Sohda M, Miyazaki T, Honjo H, Hara K, Ozawa D, Suzuki S, Tanaka N, Yokobori T, Kuwano H.
    Hepatogastroenterology; 2015 Jun 01; 62(140):898-901. PubMed ID: 26902024
    [Abstract] [Full Text] [Related]

  • 36. Failure in downregulation of intratumoral survivin expression following neoadjuvant chemoradiation in esophageal cancer.
    Vallböhmer D, Kuhn E, Warnecke-Eberz U, Brabender J, Hoffmann AC, Metzger R, Baldus SE, Drebber U, Hoelscher AH, Schneider PM.
    Pharmacogenomics; 2008 Jun 01; 9(6):681-90. PubMed ID: 18518847
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
    McKenzie S, Mailey B, Artinyan A, Metchikian M, Shibata S, Kernstine K, Kim J.
    Ann Surg Oncol; 2011 Feb 01; 18(2):551-8. PubMed ID: 20839062
    [Abstract] [Full Text] [Related]

  • 39. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
    Castoro C, Scarpa M, Cagol M, Ruol A, Cavallin F, Alfieri R, Zanchettin G, Rugge M, Ancona E.
    Ann Surg Oncol; 2011 Dec 01; 18(13):3743-54. PubMed ID: 21556952
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 58.